Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: peptide-based theranostics - Nihon Medi-Physics/PeptiDream

Next Previous
Search
Drug Profile

Research programme: peptide-based theranostics - Nihon Medi-Physics/PeptiDream

Alternative Names: Peptide-drug conjugate theranostics - Nihon Medi-Physics/PeptiDream; Peptide-radioisotope conjugate theranostics - Nihon Medi-Physics/PeptiDream

Latest Information Update: 11 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nihon Medi-Physics; PeptiDream
  • Class Drug conjugates; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Unspecified

Most Recent Events

  • 31 Mar 2025 Nihon Medi-Physics has been acquired by GE Healthcare
  • 28 Jan 2023 No recent reports of development identified for research development in Unspecified in Japan
  • 28 Jan 2023 No recent reports of development identified for research development in Unspecified(Diagnosis) in Japan

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top